The issue of polypharmacy and inappropriate medication use in post-acute and long-term care (PALTC) has been an ongoing concern. The PALTC setting has one of the highest polypharmacy rates, which increases the risk for adverse events and drug interactions.



25% reduction of medication use while optimizing the medication regimen. (in long stay patients)


Who should participate?

Prescribers, pharmacists, DONs, CNOs, CMOs, and CEOs in the long-term care setting.


What’s involved?

  • Participate in monthly calls, alternating between D2D Webinars and D2D Office Hours – an opportunity for researchers and the D2D Work Group to share their strategies, discuss resources, answer questions, etc.
  • Disseminate D2D resources to prescribers, pharmacists, and other key stakeholders in your facilities.
  • Your pharmacy partner will share aggregated data (from all participating chains and facilities) with AMDA monthly. The data will include key metrics to measure campaign success and identify areas of opportunity. The data shared with AMDA will not be down to the chain or facility level. We simply want to track the success of the initiative as a whole by identifying areas of opportunity and areas of success.


Participants Include:


Developed by: